Table 2 Literatures reporting the effects of the CONUT score on postoperative outcome in patients undergoing hepatectomy for hepatocellular carcinoma

Takagi et al. [11]

Major (CDc ≥ III):

15 vs 14% (P = 0.79)

n.a.

5-year: 27.9 vs 41.4% (P = 0.011)

HR 1.64 (1.15–2.30), P = 0.006^a

5-year: 61.9 vs 74.9% (P = 0.006)

HR 2.50 (1.47–4.23), P = 0.001^a

Harimoto et al. [12]

Major (CDc ≥ III):

20.3 vs 14.9% (P = 0.36)

n.a.

5-year: 8.8 vs 38.0% (P < 0.01)

HR 1.51 (1.06–2.15), P = 0.02^b

5-year: 47.6 vs 78.0% (P < 0.01)

HR 2.16 (1.25–3.72), P = 0.03^a

Takagi et al. [13]

Overall (CDc ≥ II):

56.7 vs 45.5% (P = 0.24)

Major (CDc ≥ III):

23.3 vs 13.6% (P = 0.15)

10.0 vs 1.3%

(P = 0.002)

OR 9.41 (1.15–77.4), P = 0.038^a

n.a.

n.a.

Harimoto et al. [14]

Major (CDc ≥ III):

17.7 vs 11.0% (P < 0.01)

n.a.

HR 1.219 (1.06–1.40), P = 0.006^a

HR 1.223 (1.06–1.41), P = 0.006^a

Li et al. [15]

Major (CDc ≥ III):

15.6 vs 6.2% (P < 0.001)

OR 2.05 (1.37–3.01), P < 0.001^a

2.6 vs 0.4%

(P = 0.001)

n.a.

n.a.

Wang et al. [16]

Overall:

74.3 vs 59.3% (P = 0.029)

n.a.

5-year: 10.0 vs 9.6% (P = 0.001)

HR 1.54 (1.10–2.16), P = 0.011^a

5-year: 31.3 vs 44.0% (P < 0.001)

HR 1.62 (1.05–2.51), P = 0.03^a

Lin et al. [17]

Overall (CDc ≥ II):

29.4 vs 23.3% (P = 0.177)

n.a.

5-year: 37.2 vs 47.6% (P = 0.016)

HR 1.36 (1.00–1.85), P = 0.052^a

5-year: 66.7 vs 82.8% (P < 0.001)

HR 2.40 (1.74–4.25), P = 0.001^a